Evidence map›Paper›PMID 28630456›Full record

ArticleMolecular psychiatry2018

Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophrenia.

S Teng, P A Thomson, S McCarthy, M Kramer, S Muller, J Lihm, S Morris, D C Soares, W Hennah, S Harris and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Differential Association of theInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Review
  6. Genetic Influences on Cognitive Dysfunction in Schizophrenia.Current topics in behavioral neurosciences · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

S TengStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
P A ThomsonCentre for Genomic and Experimental Medicine, MRC/University of Edinburgh Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.
S McCarthyStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
M KramerStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
S MullerStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
J LihmStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
S MorrisCentre for Genomic and Experimental Medicine, MRC/University of Edinburgh Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.
D C SoaresCentre for Genomic and Experimental Medicine, MRC/University of Edinburgh Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.ORCID 0000-0001-7557-0495
W HennahInstitute for Molecular Medicine, Finland FIMM, University of Helsinki, Helsinki, Finland.
S HarrisCentre for Genomic and Experimental Medicine, MRC/University of Edinburgh Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.
L M CamargoUCB New Medicines, One Broadway, Cambridge, MA, USA.
V MalkovGenetics and Pharmacogenomics, MRL, Merck & Co, Boston, MA, USA.
A M McIntoshDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
J K MillarCentre for Genomic and Experimental Medicine, MRC/University of Edinburgh Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.
D H BlackwoodDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.ORCID 0000-0002-4076-9346
K L EvansCentre for Cognitive Ageing and Cognitive Epidemiology, Edinburgh, UK.
I J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, Edinburgh, UK.
D J PorteousCentre for Genomic and Experimental Medicine, MRC/University of Edinburgh Institute of Genetics & Molecular Medicine, Western General Hospital, Edinburgh, UK.
W R McCombieStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
Western General Hospital · GBCold Spring Harbor Laboratory · USAlzheimer Scotland · GBRoyal Edinburgh Hospital · GBHoward University · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USUniversity of Helsinki · FI

Funding

Testing the DISC1 pathway for functional genetic variation and epistasis in majorR01MH102068 · NIMH · COLD SPRING HARBOR LABORATORY · PI MCCOMBIE, WILLIAM RICHARD, PORTEOUS, DAVID J · 2013 to 2015
$2.0M
Biotechnology and Biological Sciences Research Council BB/F019394/1Medical Research Council G0902166Medical Research Council MR/J004367/1Medical Research Council MR/K026992/1Medical Research Council MR/M013111/1NIMH NIH HHS R01 MH102068
6 · The paper itself

Abstract

Schizophrenia (SCZ), bipolar disorder (BD) and recurrent major depressive disorder (rMDD) are common psychiatric illnesses. All have been associated with lower cognitive ability, and show evidence of genetic overlap and substantial evidence of pleiotropy with cognitive function and neuroticism. Disrupted in schizophrenia 1 (DISC1) protein directly interacts with a large set of proteins (DISC1 Interactome) that are involved in brain development and signaling. Modulation of DISC1 expression alters the expression of a circumscribed set of genes (DISC1 Regulome) that are also implicated in brain biology and disorder. Here we report targeted sequencing of 59 DISC1 Interactome genes and 154 Regulome genes in 654 psychiatric patients and 889 cognitively-phenotyped control subjects, on whom we previously reported evidence for trait association from complete sequencing of the DISC1 locus. Burden analyses of rare and singleton variants predicted to be damaging were performed for psychiatric disorders, cognitive variables and personality traits. The DISC1 Interactome and Regulome showed differential association across the phenotypes tested. After family-wise error correction across all traits (FWER

Indexed as

AdultAgedBipolar DisorderBrainCase-Control StudiesCognitive DysfunctionFemaleGenetic Predisposition to DiseaseHumansMajor Depressive DisorderMaleMiddle AgedNerve Tissue ProteinsPolymorphism, Single NucleotideProtein Interaction MapsSchizophreniaDISC1 protein, humanNerve Tissue Proteins

Identifiers

PMID28630456
PMCPMC5984079
OpenAlexW2543944530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.